JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de JUAN](/img/nophoto.png)
![Foto de Universitat Jaume I](/img/noimage_org.png)
Universitat Jaume I
Castelló de la Plana, EspañaPublicaciones en colaboración con investigadores/as de Universitat Jaume I (22)
2024
-
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial
Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689
-
β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction
JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396
2023
-
Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 511-518
-
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction
Scientific Reports, Vol. 13, Núm. 1
-
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792
2022
-
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826
2021
-
Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure
European Journal of Internal Medicine, Vol. 92, pp. 94-99
-
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction
Journal of the American College of Cardiology, Vol. 78, Núm. 21, pp. 2042-2056
-
Matrix metalloproteinase-12 cleaved fragment of titin as a predictor of functional capacity in patients with heart failure and preserved ejection fraction
Scandinavian Cardiovascular Journal, Vol. 55, Núm. 1, pp. 9-14
2020
-
CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction
American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4
-
Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction
Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 463-470
-
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial
Journal of the American Heart Association, Vol. 9, Núm. 4
-
Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction
ESC Heart Failure, Vol. 7, Núm. 3, pp. 1007-1014
-
Right ventricular dysfunction staging system for mortality risk stratification in heart failure with preserved ejection fraction
Journal of Clinical Medicine, Vol. 9, Núm. 3
2019
-
Usefulness of Right Ventricular to Pulmonary Circulation Coupling as an Indicator of Risk for Recurrent Admissions in Heart Failure With Preserved Ejection Fraction
American Journal of Cardiology, Vol. 124, Núm. 4, pp. 567-572
2018
-
Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design
Clinical Cardiology, Vol. 41, Núm. 6, pp. 729-735
2017
-
Carga de hospitalizaciones recurrentes tras una hospitalización por insuficiencia cardiaca aguda: insuficiencia cardiaca con función sistólica conservada frente a reducida
Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 239-246
2016
-
Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial
Clinical Cardiology, Vol. 39, Núm. 8, pp. 433-439
-
Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction
International Journal of Cardiology, Vol. 207, pp. 365-367
-
Physical therapy in heart failure with preserved ejection fraction: A systematic review
European Journal of Preventive Cardiology, Vol. 23, Núm. 1, pp. 4-13